Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

NCT06865989 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT06865989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06865989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes
Lead sponsor
Insulet Corporation
Phase
Not applicable
Overall status
Completed
Start date
March 26, 2025
Completion date
November 10, 2025
Enrollment
132 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, type 2